Publication | Closed Access

A multicenter propensity score analysis of FOLFIRINOX vs gemcitabine plus nab-paclitaxel administered to patients with metastatic pancreatic cancer: results from the NAPOLEON study

Napoleon StudyPancreatic CancerGastrointestinal OncologyMedicinePharmacologyClinical TrialsPharmacotherapyMetastatic Pancreatic CancerCancer TreatmentOncologyCancer Research